GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » EBIT

Medizen Humancare Co (XKRX:236340) EBIT : ₩-2,601 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co EBIT?

Medizen Humancare Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was ₩-2,601 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-2,601 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medizen Humancare Co's annualized ROC % for the quarter that ended in Dec. 2024 was -9.73%. Medizen Humancare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -477.45%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medizen Humancare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -35.07%.

Medizen Humancare Co EBIT Historical Data

The historical data trend for Medizen Humancare Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co EBIT Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial -4,928.75 -2,535.95 -2,723.09 -1,775.28 -2,601.03

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT Get a 7-Day Free Trial -4,928.75 -2,535.95 -2,723.09 -1,775.28 -2,601.03

Competitive Comparison of Medizen Humancare Co's EBIT

For the Diagnostics & Research subindustry, Medizen Humancare Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medizen Humancare Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's EV-to-EBIT falls into.


;
;

Medizen Humancare Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-2,601 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medizen Humancare Co  (XKRX:236340) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medizen Humancare Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-1279.738 * ( 1 - 0% )/( (12941.417 + 13371.728)/ 2 )
=-1279.738/13156.5725
=-9.73 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4239.176 - 2135.771 - ( 482.555 - max(0, 13839.534 - 3001.522+482.555))
=12941.417

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3182.859 - 2677.541 - ( 446.664 - max(0, 15330.648 - 2464.238+446.664))
=13371.728

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medizen Humancare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2601.027/( ( (726.295 + max(-10686.571, 0)) + (363.262 + max(-13039.862, 0)) )/ 2 )
=-2601.027/( ( 726.295 + 363.262 )/ 2 )
=-2601.027/544.7785
=-477.45 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1770.497 + 677.332 + 37.693) - (2135.771 + 0 + 11036.322)
=-10686.571

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(903.905 + 803.236 + 55.208) - (2677.541 + 0 + 12124.67)
=-13039.862

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medizen Humancare Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-2601.027/7417.309
=-35.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medizen Humancare Co EBIT Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Medizen Humancare Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » EBIT
Comparable Companies
XKRX:086460 XKRX:149300 XKRX:031860 XKRX:246250 XKRX:229000 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA LH DGX XPAR:BIM ICLR RVTY
Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Website
http://www.medizencare.com
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co Headlines

No Headlines